Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology ↧ ↧ Novartis signs deal worth up to $3.2 billion for Alteogen's drug de... South Korea's Alteogen said on Wednesday it has signed a deal with Novartis worth up to $3.22 billion, giving the Swiss drugmaker access to its technology to make injectable versions of intravenous drugs.
published
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology ↧
Open the original public source →
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.